Friday, September 22, 2023

Truth News

  • Home
  • About Us
  • Contacts

AstraZeneca to acquire CinCor to boost its heart and kidney business

January 9, 2023

The pharma giant said CinCor’s drug could be combined with its own product – Farxiga – to help treat issues such as chronic kidney disease.

Read more: AstraZeneca to acquire CinCor to boost its heart and kidney business

Post navigation

IBM appoints Dr Nicola Hodson as CEO of UK and Ireland branch
HR Duo raises €4.5m to fuel international expansion plans

Related Posts

From tipple to tipping points: A plant geneticist on climate-resilient barley

August 1, 2023

India launches Aditya space mission to study the sun

September 4, 2023

Tyndall joins EU initiative to tackle key quantum ‘bottleneck’

April 4, 2023

Recent Posts

  • Amazon to introduce ads on Prime Video starting next year
  • Cork medtech develops preeclampsia screening test
  • Intel hit with €376m EU fine in long-running antitrust dispute
  • Silicon Republic’s almost A-Z list of tech jobs
  • EV charging start-up GoPlugable takes top prize at Invent 2023

Popular posts

  • ‘Companies must understand their operations before building shiny new tools’
  • €21.3m all-island programme to train 42 ‘world-class clinician scientists’
  • UK watchdog confirms ruling requiring Meta to sell Giphy

Subscribe to newsletters

Subscribed successfully





truth-news.online © 2023 | Privacy Policy
  • About Us
  • Contacts
  • Privacy Policy
Generated by Feedzy